Aster Capital Management DIFC Ltd Boosts Stake in Kenvue Inc. $KVUE

Aster Capital Management DIFC Ltd increased its stake in Kenvue Inc. (NYSE:KVUE) by 1,241.9% during the third quarter, Holdings Channel.com reports. The firm owned 49,085 shares of the company’s stock after purchasing an additional 45,427 shares during the quarter. Aster Capital Management DIFC Ltd’s holdings in Kenvue were worth $797,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Salomon & Ludwin LLC purchased a new stake in Kenvue in the third quarter worth about $25,000. NBT Bank N A NY lifted its position in shares of Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in shares of Kenvue by 705.2% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after buying an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC grew its stake in shares of Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after acquiring an additional 1,190 shares during the period. Finally, Trust Co. of Vermont increased its holdings in Kenvue by 50.9% in the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on KVUE shares. Citigroup raised their target price on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. UBS Group increased their price objective on shares of Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Canaccord Genuity Group lifted their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Finally, Jefferies Financial Group cut Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the company from $23.00 to $18.00 in a report on Friday, January 30th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $19.50.

Kenvue Trading Up 1.2%

KVUE stock opened at $19.00 on Friday. The firm has a fifty day moving average price of $17.68 and a 200 day moving average price of $17.57. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The firm has a market cap of $36.42 billion, a PE ratio of 24.68, a price-to-earnings-growth ratio of 4.30 and a beta of 0.59. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.96.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. During the same quarter in the prior year, the firm earned $0.26 earnings per share. Kenvue’s revenue was up 3.2% on a year-over-year basis. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were issued a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Insider Buying and Selling

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The stock was bought at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.68% of the company’s stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.